Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases

By Blom R.   Guerrieri C.   Stal O.   Malmstrom H.   Simonsen E.  

Gynecologic Oncology, Vol. 68, Iss. 1, 1998-01 ,pp. : 54-61

Elsevier

Access to resources Recommend Favorite

Chemotherapy for Malignant Mixed Mullerian Tumors of the Ovary

By Sit A.S.Y.   Price F.V.   Kelley J.L.   Comerci J.T.   Kunschner A.J.   Kanbour-Shakir A.   Edwards R.P.  

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 196-200

Elsevier

Access to resources Recommend Favorite

Myasthenia Gravis Associated with Malignant Mixed Mullerian Tumor of the Uterus

By Ariad S.   Geffen D.B.   Yanai-Inbar I.   Zalmanov S.   Piura B.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 510-515

Elsevier

Access to resources Recommend Favorite

The Expression of Epidermal Growth Factor Receptor, HER-2/ Neu, p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

By Swisher E.M.   Gown A.M.   Skelly M.   Ek M.   Tamimi H.K.   Cain J.M.   Greer B.E.   Muntz H.G.   Goff B.A.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 81-88

Academic Press

Access to resources Recommend Favorite

Evidence for a Common Etiology for Endometrial Carcinomas and Malignant Mixed Mullerian Tumors

By Zelmanowicz A.   Hildesheim A.   Sherman M.E.   Sturgeon S.R.   Kurman R.J.   Barrett R.J.   Berman M.L.   Mortel R.   Twiggs L.B.   Wilbanks G.D.   Brinton L.A.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 253-257

Elsevier

Access to resources Recommend Favorite